Non-alcoholic fatty liver disease ultrasound: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(11 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Non alcoholic fatty liver disease}}
{{Non alcoholic fatty liver disease}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{MKK}}
 
{{PleaseHelp}}
   
   
==Overview==
==Overview==


here are no echocardiography/ultrasound findings associated with [disease name].
[[Ultrasound]] may be helpful in the diagnosis of non-alcoholic fatty liver disease. Increased echogenicity and coarsened echotexture of the liver is the most prominent and diagnostic finding on an ultrasound in patients diagnosed non-alcoholic fatty liver disease.
 
OR
 
Echocardiography/ultrasound  may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
 
OR
 
There are no echocardiography/ultrasound  findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].


==Ultrasound==
==Ultrasound==
 
*Ultrasound is considered as the first line of imaging choice for NAFLD patients
*There are no echocardiography/ultrasound  findings associated with [disease name].
*Ultrasound have senstivity of 60-100 and 80-100 % of positive predictive value.
OR
*Findings on an ultrasound suggestive of non-alcoholic fatty liver disease include:
*Echocardiography/ultrasound  may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include:
**Moderate to high amount of fatty infiltration of liver which is reflected as increased echogenicity and coarsened echotexture of the liver.
**[Finding 1]
** If steato-hepatitis has progressed to cirrhosis, a nodular liver surface may be present in addition to other fibrotic changes.<ref name="pmid28994271">{{cite journal |vauthors=Lee DH |title=Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification |journal=Clin Mol Hepatol |volume= |issue= |pages= |year=2017 |pmid=28994271 |doi=10.3350/cmh.2017.0042 |url=}}</ref>
**[Finding 2]
*Ultrasound elastography is another kind of ultrasound that can give [[qualitative]] progression of the liver fibrosis.
**[Finding 3]
*The only limitation of using an ultrasound is that it cannot differentiate between [[hepatic fibrosis]] and [[steatosis]].
OR
*There are no echocardiography/ultrasound  findings associated with [disease name]. However, an echocardiography/ultrasound  may be helpful in the diagnosis of complications of [disease name], which include:
**[Complication 1]
**[Complication 2]
**[Complication 3]
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 03:24, 30 July 2018

Non-Alcoholic Fatty Liver Disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Non-alcoholic fatty liver disease ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-alcoholic fatty liver disease ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-alcoholic fatty liver disease ultrasound

CDC on Non-alcoholic fatty liver disease ultrasound

Non-alcoholic fatty liver disease ultrasound in the news

Blogs on Non-alcoholic fatty liver disease ultrasound

Directions to Hospitals Treating Non-alcoholic fatty liver disease

Risk calculators and risk factors for Non-alcoholic fatty liver disease ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Ultrasound may be helpful in the diagnosis of non-alcoholic fatty liver disease. Increased echogenicity and coarsened echotexture of the liver is the most prominent and diagnostic finding on an ultrasound in patients diagnosed non-alcoholic fatty liver disease.

Ultrasound

  • Ultrasound is considered as the first line of imaging choice for NAFLD patients
  • Ultrasound have senstivity of 60-100 and 80-100 % of positive predictive value.
  • Findings on an ultrasound suggestive of non-alcoholic fatty liver disease include:
    • Moderate to high amount of fatty infiltration of liver which is reflected as increased echogenicity and coarsened echotexture of the liver.
    • If steato-hepatitis has progressed to cirrhosis, a nodular liver surface may be present in addition to other fibrotic changes.[1]
  • Ultrasound elastography is another kind of ultrasound that can give qualitative progression of the liver fibrosis.
  • The only limitation of using an ultrasound is that it cannot differentiate between hepatic fibrosis and steatosis.

References

  1. Lee DH (2017). "Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification". Clin Mol Hepatol. doi:10.3350/cmh.2017.0042. PMID 28994271.

Template:WS Template:WH